The Hospital General Universitario Gregorio Marañón is a public general hospital located at the neighborhood of Ibiza in Madrid, Spain, part of the hospital network of the Servicio Madrileño de Salud.

There are 1,671 beds in Hospital General Universitario Gregorio Marañon; Servicio de Oncologia.

During the past decade, Hospital General Universitario Gregorio Marañon; Servicio de Oncologia conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 29 clinical trials were completed, i.e. on average, 61.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 14 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 46 trials, followed by "Bayer" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "ACADIA Pharmaceuticals Inc." with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" are "Breast Cancer" (8 trials), "Ovarian Cancer" (4 trials), "Bladder Cancer" (3 trials), "Colorectal Cancer" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" are "Drug" (62 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (23 trials), "Placebo" (15 trials), "Carboplatin" (12 trials), "Paclitaxel" (11 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia" are 51 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Universitario Gregorio Marañon; Servicio de Oncologia". undefined are not yet recruiting, 14 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".